InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,222.40
(
0.25%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.83
(
0.76%
)
Bitcoin
61,369.28
(
-0.71%
)
Post# of 18067
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

stills999

Send PM Follow Ignore
Followers 18
Posts 3253
Boards Moderated 1
Alias Born 01/20/2010

stills999

Re: None

Wednesday, 04/10/2013 5:01:05 PM

Wednesday, April 10, 2013 5:01:05 PM

Post# of 18067
INO - good news today, but bad news last week. I understand that the Chrontech vacine (which leverages INO's electroportation) is one of the less important trials but I need to investigate whether or not this poor result has any bearing on INO's proprietary vaccine trials.


"Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device"

http://ih.advfn.com/p.php?pid=nmona&article=57102567&symbol=INO

"Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection"

http://ih.advfn.com/p.php?pid=nmona&article=56984006

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up